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Brief Definitive Report 
CARBOHYDRATE MOIET IES OF MAJOR 
H ISTOCOMPATIB IL ITY  COMPLEX CLASS I ALLOANTIGENS 
ARE NOT REQUIRED FOR THEIR  RECOGNIT ION BY T 
LYMPHOCYTES 
BY STEVEN A. N. GOLDSTEIN AND MATTHEW F. MESCHER 
From the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 
Cytotoxic T lymphocytes (CTL) have been implicated as effectors in allograft 
rejection and in control of viral infection. Induction of a cytolytic response 
requires T cell recognition of foreign major histocompatibility complex (MHC) 
class I glycoproteins, or syngeneic MHC antigens along with a foreign (i.e., viral) 
protein. This recognition process leads to proliferation and differentiation of 
precursor cells to effector CTL capable of lysing target cells that bear the same 
antigens. While class I oligosaccharide r sidues do not contribute to serologic 
determinants (1-4) their role in T cell recognition has remained unclear. Modi- 
fication of the carbohydrates of membrane glycoproteins on intact stimulating 
or target cells has been observed to inhibit (1, 5, 6), stimulate (7, 8), or have no 
effect (2, 6, 9) on T cell responses. In all of these cases, it is difficult to conclude 
whether the observed effects were due to altered MHC antigen oligosaccharides, 
since modifications could not be limited to the surface glycoprotein of interest, 
and the extent of modification could not be readily determined. 
Class I antigens of the murine MHC (H-2) are polymorphic two-chain cell 
surface glycoproteins consisting of a glycosylated transmembrane h avy chain 
(Mr 40,000-50,000) noncovalently associated with /32-microglobulin, an invar- 
iant, nonglycosylated polypeptide (Mr 1 1,500). Amino acid and DNA sequence 
data suggest that the extracellular portion of the heavy chain can be divided into 
three globular domains of ~91 amino acids each (~, c~z, and as). Determinants 
recognized by T cells appear to reside in the c~l and a2 domains (10), regions of 
maximal amino acid variability (11). Glycosyl moieties are also present in these 
regions, N-linked to asparagine r sidues at positions 86 and 176. A third glycan 
attachment site in K d, D b, and L d antigens i at residue 256 (11). 
Purified class I alloantigen i  artificial membranes (liposomes) can stimulate a 
CTL response of comparable magnitude to that obtained using intact stimulating 
cells when added to in vitro cultures of spleen cells from mice previously primed 
to the same alloantigen (12). The magnitude of the response to the liposomes 
provides a direct measure of the effectiveness of antigen recognition by primed 
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precursor CTL  (pCTL), provided that an optimum amount of interleukin- 
containing supernatant is added (12). This approach has made it possible to 
examine the role of the carbohydrate moieties in class I MHC recognition. 
Mater ials and Methods  
Mice and Tumor Cells. (BALB/c × DBA/2)F~ (CD2F1) (H-2 d) mice were purchased 
from Cumberland View Farms, Clinton, TN. (AKR × DBA/2)FI (AKD2F1) (H-2 kxd) and 
A/J (H-2 ") were purchased from The Jackson Laboratory, Bar Harbor, ME. RDM-4 (H- 
2k), an AKR lymphoma, and P815 (H-2d), a mastocytoma of DBA/2 origin, were main- 
tained by intraperitoneal passage as ascites in AKD2F~ mice. 
Put,cation of Native and RadiolabeUed H-2K k. H-2K k was purified from RDM-4 ascites 
cell detergent lysates by affinity chromatography on an 11-4.1 monoclonal ntibody (mAb) 
column (12) with a yield of 0.9 mg H-2K k per 101° cells. Internally radiolabeled H-2K ~ 
was purified from RDM-4 cells cultured in glucose- or methionine-deficient RPMI 1640 
(Gibco Laboratories, Grand Island, NY) with [SH]mannose or [sSS]methionine, and 5% 
dialyzed fetal calf serum. 125I-H-2Kk was prepared by reacting 10 #g purified antigen with 
0.5 mCi Nal~SI and two Iodobeads (Pierce Chemical Corp., Rockford, IL) in 0.15 ml 
0.5% deoxycholate for 30 rain at 4°C, and isolated by Sephadex G-25 chromatography 
and dialysis, yielding a product with a specific activity of 400 cpm/ng ~rotein. 
Preparation of Liposomes and Deglycosylated H-2K k. Purified H-2K was incorporated 
into unilamellar liposomes by mixing with lipid (1 #g H-2K k per 10 nmol phospholipid) in
0.5% deoxycholate, followed by dialysis to remove the detergent (12). Liposomes were 
harvested by centrifugation at 100,000 g for 60 rain, and resuspended in 33 mM EDTA, 
10 mM Tris maleate, 170 mM NaC1, pH 6.1. Liposomes containing 5 #g H-2K k were 
subjected to either limited (1 U enzyme for 4 h) or exhaustive (4 U for 21 h) endoglyco- 
sidase F treatment (endo F) (EC-3.2.1; New England Nuclear, Boston, MA) at 37°C. 
Controls without enzyme were incubated in parallel at 4°C and 37°C. In some experi- 
ments, liposomes were reisolated from the enzymatic reaction mixture by centrifugation. 
All H-2K k preparations were analyzed by sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) on 5-15% slab gels. 
Effector CTL Generation and Cytotoxicity. Liposomes were added to responder spleno- 
cytes fiom CD2FI mice primed 2-4 mo previously by intraperitoneal injection of 2 × 107 
RDM-4 cells, and cultured in 2 ml of medium with 7 × 106 cells/well (Linbro Chemical 
Co., Hamden, CT) at 37°C and 5% COs. An optimal concentration of an (NH4)2SO4 
fraction of supernatant fluid from rat spleen cells incubated with concanavalin A (I 2) was 
added at 22 h of culture. After 5 d, the cultures were assayed for cytotoxicity at several 
effector/target cell ratios by triplicate determination f the 5~Cr eleased in 4 h from 1.5 
x 104 labelled RDM-4 target cells incubated at 37°C. Medium was RPMI 1640 supple- 
mented as previously described (12). 
Results 
Endo F was used to obtain deglycosylated H-2K k. This enzyme cleaves high- 
mannose and complex-type asparagine-linked glycans, leaving a single N-acetyl- 
glucosamine residue attached to the protein (13). The  glycan-bearing heavy 
chain of native H-2K k is of 48,000 Mr when examined by SDS-PAGE and 
autoradiography (Fig. 1, lane 1). In contrast, three heavy chain products were 
found when H-2K k was incorporated into liposomes and subjected to limited 
endo F treatment (Fig. l, lane 2). These had Mr of 48,000, corresponding to 
native H-2K k, 45,000, and 42,000. While the 48,000 and 45,000 Mr products 
were bound by lentil lectin-Sepharose, the 42,000 product was not (data not 
shown). This indicated that the 45,000 Mr product retained one of  the two 
original carbohydrate moieties, and that the 42,000 product was fully deglyco- 
sylated. Tunicamycin treatment of  cells to inhibit l ipid-dependent protein gly- 
cosylation yields a mixture of  H-2K k beavy chain products, including a fully 
deglycosylated species with an Mr 6,000 smaller than native antigen (3). 
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FIGURE 1. Deglycosylation f H-2K k. Purified H-2K k in liposomes was subjected to limited 
or complete deglycosylation byendo F (EF) and analyzed by SDS-PAGE. Protein bands were 
visualized by autoradiography (1~51) or staining with Coomassie Blue (CB) and fluorography 
(SH). Liposomes containing 5 #g of H-2K k and 5 × I0 s cpm in 0.05 ml underwent the following 
endo F treatments: lane 1, no enzyme, 4 h, 37°C; lane 2, 1 U enzyme for 4 h, 37°C; lanes 3 
and 4, no enzyme, 21 h incubation at 4°C; lanes 5 and 6, no enzyme, 21 h, 37°C; lanes 7 and 
8, 4 U, 21 h, 37°C; lane 9, 1 U endo F without liposomes. 
Extensive ndo F treatment of liposomes bearing H-2K k resulted in complete 
conversion of heavy chains to the 42,000 Mr product, as demonstrated by 
Coomassie Blue staining after SDS-PAGE (Fig. 1, lane 7). Incubation ofliposomes 
for the same length of time at either 4°C (lane 3) or 37°C (lane 5) in the absence 
of enzyme resulted in no change in the Mr of heavy chains. The absence of 
oligosaccharides in the 42,000 M, product was confirmed by examination of H- 
2K k biosynthetically abelled with [3H]mannose. No detectable radioactivity 
remained associated with the 42,000 Mr product resulting from endo F treatment 
(Fig. 1, lane 8), while controls retained the labelled glycans (lanes 4 and 6). The 
observation that all heavy chains are deglycosylated confirms that the antigen is 
asymmetrically oriented on the external face of these sealed unilamellar vesicles. 
Treatment with endo F resulted in no change in the M, of/32-microglobulin 
(Fig. 1), nor in its association with heavy chain, as assessed by radioactivity 
recovered from the bands in gels of deglycosylated 125I-H-2Kk. Serological activity 
detected by the 11-4.1 mAb was also unaffected, since immunoprecipitation of 
deglycosylated [35S]methionine-labelled H-2K k was 92% that of native labelled 
antigen (data not shown). These observations are consistent with studies of H-2 
and HLA class I antigens indicating that carbohydrate groups do not affect heavy 
and light chain association (4), or contribute to alloantigenic serologic determi- 
nants (1-4). In fact, blocking glycosylation does not prevent synthesis and 
expression of serologically active antigen at the cell surface (1, 4). 
The ability of pCTL to recognize and respond to native or deglycosylated H- 
2K k on liposomes was assessed by measuring their maturation to effector CTL 
capable of lysing antigen-bearing target cells. Addition to cultures of liposomes 
bearing either native or deglycosylated H-2K k resulted in strong and comparable 
responses (Fig. 2 A). No cytolytic response was obtained in the absence of antigen- 
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FIGURE 2. A, Precursor CTL recognition of native and deglycosylated H-2K k. Immune 
recognition was assessed by the development of cytotoxicity towards 5~Cr-labelled RDM-4 
target cells in cultures of primed CD2FI responder splenocytes incubated for 5 d with: (A) 
medium only; (O) 0.125 #g/ml native H-2K k in liposomes; (O) 0.125 •g/mt deglycosylated H-
2K k in liposomes; (A) 0.75 U/ml endo F. The native and deglycosylated H-2Kk-bearing 
liposome preparations added to these cultures were analyzed in Fig. 1. Percent specific 5~Cr 
release = 100 X (experimental - spontaneous SlCr release)/(total releasable - spontaneous 
5'Cr release). Spontaneous release was <:18% for all experiments. B, Generation of effector 
CTL by increasing doses of native and deglycosylated H-2K k. Liposomes were subjected to 
exhaustive endo F treatment (4U, 21 h, 37 °C), or parallel control incubations without enzyme 
at 4°C or 37°C; reisolated from incubation mixtures by centrifugation, and suspended in 
medium for culture. A trace of 2~51-H-2Kk was included in the liposome preparation to permit 
antigen quantitation. Endo F-treated liposomes were confirmed to bear only deglycosylated 
H-2K k by SDS-PAGE and autoradiography, while incubation in the absence of enzyme resulted 
in no change in the Mr of the heavy chain. Cytotoxicity was measured after CD2F~ responder 
splenocytes were cultured for 5 d with liposomes bearing: (@) deglycosylated H-2Kt; (A) native 
H-2K k (pretreated at4°C); (O) native H-2K k (pretreated at37°C). 1 pmol of native H-2K t is 
equivalent to 0.048 ~g. Lytic units provide an estimate of the relative number of effector CTL 
in a population. One lytic unit is defined as the number of cultured cells required to ]yse 50% 
of the target cells in the 4-h 5JCr release assay. 
bear ing liposomes, nor  after addit ion o f  endo F alone to cells in culture (Fig. 
2A). Fur thermore ,  neither the presence (Fig. 2A) nor  the absence (Fig. 2B) of  
the enzyme in cultures with l iposomes affected the level o f  response obtained to 
either native or  deglycosylated antigen. 
The  response to native and deglycosylated H-2K k was examined over a wide 
range of  antigen concentrat ions to rule out the possibility that a small amount  
o f  native H-2K k remain ing in the endo  F - t reated  samples might account  for the 
observed stimulation. The  deglycosylated antigen was found to stimulate some- 
what more efficiently over the entire dose range for  the response (Fig. 2B). This 
augmentat ion  was observed with four  independent  preparations, and may result 
f rom decreased repulsion between treated l iposomes and negatively charged 
surfaces o f  pCTL .  In fact, removal  o f  negatively charged sialic acid by neur-  
aminidase increases target cell sensitivity to CTL  (7, 8). Stability o f  the H-2K k 
molecule in either its native or  deglycosylated state is underscored by mainte- 
nance o f  immunogenic i ty  despite overnight  incubation at 37 °C. 
To  rule out possible nonspecif ic mitogenic effects o f  the deglycosylated class I 
antigen, the specificity o f  CTL  induction and o f  the result ing effector cells was 
examined (data not shown). When splenocytes f rom A/ J  (H-2K k) mice previously 
immunized with P815 (H-2K d) cells were cultured for 5 d in the presence of  
plasma membranes  f rom P815 cells, effector CTL  were generated that lysed 
P815 but not RDM-4 targets. Culture o f  the same cells with l iposomes bear ing 
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either native or deglycosylated H-2K k resulted in no response using either tumor 
cell target. These liposomes, at the same and lower concentrations, stimulated a 
strong response by CD2FI spleen cells, and the resulting effectors were specific 
for target cells bearing the appropriate H-2K k alloantigen. 
Discussion 
Liposomes bearing completely deglycosylated H-2K k have been shown in this 
report to trigger the maturation of precursor to effector CTL as effectively as 
liposomes with native antigen. It follows that class I oligosaccharide moieties do 
not contribute to alloantigenic determinants recognized by the majority of splenic 
pCTL. If a small number of pCTL can recognize determinants hat include the 
carbohydrate, they constitute a minor portion of the aliogeneic response. These 
results also show that induction of the cytolytic response does not require non- 
antigen specific interaction of H-2K k glycan moieties with either the T cell 
receptor or accessory molecules. A role for carbohydrates in other accessory 
interactions during target cell binding or lysis cannot be ruled out. 
Recently, site-directed mutagenesis was used to delete the oligosaccharide at
position 86 in H-2L d by substituting the original asparagine with a lysine residue, 
which is not glycosylated (14). Mouse L cell transfectants expressed the mutant 
product and were recognized by H-2Ld-reactive CTL. However, a limited 
number of conclusions can be drawn from this report regarding the role of H-2 
oligosaccharides in T cell recognition. Only one of the three carbohydrate 
residues present in H-2L d was removed. Further, as noted by the authors, 
mutagenesis not only removed the glycan at position 86, but substituted another 
amino acid, which may affect conformational changes unrelated to the absence 
of the oligosaccharide. Finally, while the use of liposomes allowed quantitative 
assessment of the functional effects of removing all the carbohydrate from native 
H-2K k, the gene transfer esults are qtialitative, as they are complicated by varied 
levels of antigen expression on different transfectants and by assumptions re- 
garding the effect this might have on cytolysis by CTL. 
The use of purified MHC antigen in liposomes to assess tructural requirements 
for T cell recognition provides several advantages over use of modified whole 
stimulator cells. The modification can be confined to the antigen of interest, and 
the extent of modification can be readily determined. Furthermore, the dose 
response to the antigen or its modified forms can be accurately quantitated. The 
importance of this is indicated by the observation that removal of >90% of the 
H-2 from the surface of allogeneic ells by papain treatment did not decrease 
the CTL recognition of these cells (15). Thus, modification or removal of >90% 
of a critical antigen structure on intact cells can appear to have no effect. 
Summary 
The ability to generate specific cytotoxic responses using purified major 
histocompatibility complex (MHC) antigen in liposomes has made it possible to 
directly assess the importance of class I carbohydrate moieties in T cell recogni- 
tion of alloantigen. Deglycosylation of affinity-purified H-2K k to yield a single 
glycan-free product did not alter the specificity, the magnitude, nor the dose 
range of the cytotoxic T lymphocyte (CTL) response to the class I antigen. It 
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can be concluded that carbohydrate moieties are not required to maintain the 
necessary conformation of the MHC protein, nor to interact with either the 
antigen-specific receptor or accessory proteins on precursor CTL.  
Received for publication 4June 1985 and in revised form 18July 1985. 
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